The global Human Genome Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Genome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Genome Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Genome Sequencing in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Genome Sequencing include 10x Genomics, 23andME, Abbott, AccuraGen, Adaptive Biotechnologies, Admera Health, Agena Bioscience, Agilent Technologies and Akonni Biosystems, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Genome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Genome Sequencing.
Report Scope
The Human Genome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Genome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Genome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
23andME
Abbott
AccuraGen
Adaptive Biotechnologies
Admera Health
Agena Bioscience
Agilent Technologies
Akonni Biosystems
Ancestry
AnchorDx
Arc Bio
ArcherDx
ARUP Laboratories
Asuragen
Baylor Genetics
Beckman Coulter
Becton, Dickinson and Company
BGI Genomics
Segment by Type
Emulsion Polymerase Chain Reaction
Bridge Amplification
Single Molecule
Segment by Application
Hospitals and Clinics
Independent Clinical Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Genome Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Genome Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Emulsion Polymerase Chain Reaction
1.2.3 Bridge Amplification
1.2.4 Single Molecule
1.3 Market by Application
1.3.1 Global Human Genome Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Independent Clinical Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Genome Sequencing Market Perspective (2019-2030)
2.2 Human Genome Sequencing Growth Trends by Region
2.2.1 Global Human Genome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Genome Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Human Genome Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Human Genome Sequencing Market Dynamics
2.3.1 Human Genome Sequencing Industry Trends
2.3.2 Human Genome Sequencing Market Drivers
2.3.3 Human Genome Sequencing Market Challenges
2.3.4 Human Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Genome Sequencing Players by Revenue
3.1.1 Global Top Human Genome Sequencing Players by Revenue (2019-2024)
3.1.2 Global Human Genome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Human Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Genome Sequencing Revenue
3.4 Global Human Genome Sequencing Market Concentration Ratio
3.4.1 Global Human Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Genome Sequencing Revenue in 2023
3.5 Human Genome Sequencing Key Players Head office and Area Served
3.6 Key Players Human Genome Sequencing Product Solution and Service
3.7 Date of Enter into Human Genome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Genome Sequencing Breakdown Data by Type
4.1 Global Human Genome Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Human Genome Sequencing Forecasted Market Size by Type (2025-2030)
5 Human Genome Sequencing Breakdown Data by Application
5.1 Global Human Genome Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Human Genome Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Genome Sequencing Market Size (2019-2030)
6.2 North America Human Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Genome Sequencing Market Size by Country (2019-2024)
6.4 North America Human Genome Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Genome Sequencing Market Size (2019-2030)
7.2 Europe Human Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Genome Sequencing Market Size by Country (2019-2024)
7.4 Europe Human Genome Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Genome Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Human Genome Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Genome Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Genome Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Genome Sequencing Market Size (2019-2030)
9.2 Latin America Human Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Genome Sequencing Market Size by Country (2019-2024)
9.4 Latin America Human Genome Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Genome Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Human Genome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Genome Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Genome Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Human Genome Sequencing Introduction
11.1.4 10x Genomics Revenue in Human Genome Sequencing Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 23andME
11.2.1 23andME Company Detail
11.2.2 23andME Business Overview
11.2.3 23andME Human Genome Sequencing Introduction
11.2.4 23andME Revenue in Human Genome Sequencing Business (2019-2024)
11.2.5 23andME Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Human Genome Sequencing Introduction
11.3.4 Abbott Revenue in Human Genome Sequencing Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 AccuraGen
11.4.1 AccuraGen Company Detail
11.4.2 AccuraGen Business Overview
11.4.3 AccuraGen Human Genome Sequencing Introduction
11.4.4 AccuraGen Revenue in Human Genome Sequencing Business (2019-2024)
11.4.5 AccuraGen Recent Development
11.5 Adaptive Biotechnologies
11.5.1 Adaptive Biotechnologies Company Detail
11.5.2 Adaptive Biotechnologies Business Overview
11.5.3 Adaptive Biotechnologies Human Genome Sequencing Introduction
11.5.4 Adaptive Biotechnologies Revenue in Human Genome Sequencing Business (2019-2024)
11.5.5 Adaptive Biotechnologies Recent Development
11.6 Admera Health
11.6.1 Admera Health Company Detail
11.6.2 Admera Health Business Overview
11.6.3 Admera Health Human Genome Sequencing Introduction
11.6.4 Admera Health Revenue in Human Genome Sequencing Business (2019-2024)
11.6.5 Admera Health Recent Development
11.7 Agena Bioscience
11.7.1 Agena Bioscience Company Detail
11.7.2 Agena Bioscience Business Overview
11.7.3 Agena Bioscience Human Genome Sequencing Introduction
11.7.4 Agena Bioscience Revenue in Human Genome Sequencing Business (2019-2024)
11.7.5 Agena Bioscience Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Human Genome Sequencing Introduction
11.8.4 Agilent Technologies Revenue in Human Genome Sequencing Business (2019-2024)
11.8.5 Agilent Technologies Recent Development
11.9 Akonni Biosystems
11.9.1 Akonni Biosystems Company Detail
11.9.2 Akonni Biosystems Business Overview
11.9.3 Akonni Biosystems Human Genome Sequencing Introduction
11.9.4 Akonni Biosystems Revenue in Human Genome Sequencing Business (2019-2024)
11.9.5 Akonni Biosystems Recent Development
11.10 Ancestry
11.10.1 Ancestry Company Detail
11.10.2 Ancestry Business Overview
11.10.3 Ancestry Human Genome Sequencing Introduction
11.10.4 Ancestry Revenue in Human Genome Sequencing Business (2019-2024)
11.10.5 Ancestry Recent Development
11.11 AnchorDx
11.11.1 AnchorDx Company Detail
11.11.2 AnchorDx Business Overview
11.11.3 AnchorDx Human Genome Sequencing Introduction
11.11.4 AnchorDx Revenue in Human Genome Sequencing Business (2019-2024)
11.11.5 AnchorDx Recent Development
11.12 Arc Bio
11.12.1 Arc Bio Company Detail
11.12.2 Arc Bio Business Overview
11.12.3 Arc Bio Human Genome Sequencing Introduction
11.12.4 Arc Bio Revenue in Human Genome Sequencing Business (2019-2024)
11.12.5 Arc Bio Recent Development
11.13 ArcherDx
11.13.1 ArcherDx Company Detail
11.13.2 ArcherDx Business Overview
11.13.3 ArcherDx Human Genome Sequencing Introduction
11.13.4 ArcherDx Revenue in Human Genome Sequencing Business (2019-2024)
11.13.5 ArcherDx Recent Development
11.14 ARUP Laboratories
11.14.1 ARUP Laboratories Company Detail
11.14.2 ARUP Laboratories Business Overview
11.14.3 ARUP Laboratories Human Genome Sequencing Introduction
11.14.4 ARUP Laboratories Revenue in Human Genome Sequencing Business (2019-2024)
11.14.5 ARUP Laboratories Recent Development
11.15 Asuragen
11.15.1 Asuragen Company Detail
11.15.2 Asuragen Business Overview
11.15.3 Asuragen Human Genome Sequencing Introduction
11.15.4 Asuragen Revenue in Human Genome Sequencing Business (2019-2024)
11.15.5 Asuragen Recent Development
11.16 Baylor Genetics
11.16.1 Baylor Genetics Company Detail
11.16.2 Baylor Genetics Business Overview
11.16.3 Baylor Genetics Human Genome Sequencing Introduction
11.16.4 Baylor Genetics Revenue in Human Genome Sequencing Business (2019-2024)
11.16.5 Baylor Genetics Recent Development
11.17 Beckman Coulter
11.17.1 Beckman Coulter Company Detail
11.17.2 Beckman Coulter Business Overview
11.17.3 Beckman Coulter Human Genome Sequencing Introduction
11.17.4 Beckman Coulter Revenue in Human Genome Sequencing Business (2019-2024)
11.17.5 Beckman Coulter Recent Development
11.18 Becton, Dickinson and Company
11.18.1 Becton, Dickinson and Company Company Detail
11.18.2 Becton, Dickinson and Company Business Overview
11.18.3 Becton, Dickinson and Company Human Genome Sequencing Introduction
11.18.4 Becton, Dickinson and Company Revenue in Human Genome Sequencing Business (2019-2024)
11.18.5 Becton, Dickinson and Company Recent Development
11.19 BGI Genomics
11.19.1 BGI Genomics Company Detail
11.19.2 BGI Genomics Business Overview
11.19.3 BGI Genomics Human Genome Sequencing Introduction
11.19.4 BGI Genomics Revenue in Human Genome Sequencing Business (2019-2024)
11.19.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
10x Genomics
23andME
Abbott
AccuraGen
Adaptive Biotechnologies
Admera Health
Agena Bioscience
Agilent Technologies
Akonni Biosystems
Ancestry
AnchorDx
Arc Bio
ArcherDx
ARUP Laboratories
Asuragen
Baylor Genetics
Beckman Coulter
Becton, Dickinson and Company
BGI Genomics
*If Applicable.